Advertisement
Advertisement

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

13.74
USD
Sponsored
-0.09
-0.65%
Feb 02, 15:59 UTC -5
Closed
exchange

After-Market

13.71

-0.03
-0.22%

PLSE Earnings Reports

Positive Surprise Ratio

PLSE beat 9 of 22 last estimates.

41%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$255.00K
/
-$0.32
Implied change from Q3 25 (Revenue/ EPS)
+196.51%
/
+14.29%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+88.24%

Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue

On Nov 05, 2025, PLSE reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.31 USD, resulting in a 8.29% surprise. Revenue reached 86.00 thousand, compared to an expected 510.00 thousand, with a -83.14% difference. The market reacted with a -3.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 255.00 thousand USD, implying an increase of 14.29% EPS, and increase of 196.51% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.09%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
For Q3 2025, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.28, beating estimates by 8.29%, and revenue of $86.00K, -83.14% below expectations.
The stock price moved down -3.32%, changed from $16.27 before the earnings release to $15.73 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 3 analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.32 and revenue of $255.00K for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement